Position
BARCLAYS PLC in Editas Medicine, Inc.
Back to the book · All holders of EDIT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $61.2K$2.05 → $2.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2022 | 440.4K | $3.91M | — | — | — | 0.0% |
| Q1 2023 | 275.1K | $1.99M | $7.25 | −$445.7K | −$1.47M | 0.0% |
| Q2 2023 | 299.3K | $2.46M | $8.23 | $269.6K | $198.9K | 0.0% |
| Q3 2023 | 275K | $2.15M | $7.80 | −$118.3K | −$199.7K | 0.0% |
| Q4 2023 | 279.4K | $2.83M | $10.13 | $640.8K | $44.8K | 0.0% |
| Q1 2024 | 144.7K | $1.07M | $7.42 | −$392.2K | −$1.36M | 0.0% |
| Q2 2024 | 121.5K | $567.5K | $4.67 | −$334.2K | −$172.2K | 0.0% |
| Q3 2024 | 178.5K | $608.7K | $3.41 | −$153.1K | $194.3K | 0.0% |
| Q4 2024 | 181.2K | $230.2K | $1.27 | −$382K | $3.47K | 0.0% |
| Q1 2025 | 141.2K | $163.8K | $1.16 | −$15.5K | −$50.9K | 0.0% |
| Q2 2025 | 199.5K | $439K | $2.20 | $146.8K | $128.4K | 0.0% |
| Q3 2025 | 187.1K | $649.1K | $3.47 | $237.6K | −$27.5K | 0.0% |
| Q4 2025 | 276.3K | $566.3K | $2.05 | −$265.6K | $182.9K | 0.0% |
| Q1 2026 | 145.6K | $359.6K | $2.47 | $61.2K | −$267.9K | 0.0% |